Topics
-
ANTITRUST
-
Asset Management
-
Digital Health
-
Employee Benefits/ERISA
-
Enforcement
-
False Claims Act
-
FDA REGULATORY
- Health Care
-
Intellectual Property
-
PRIVATE EQUITY
-
TAX
Capital Insights
Analysis
- Podcast: Hedging with a Purpose: An Overview of Derivatives in Sustainable Finance
(February 17, 2021) - Chinese Government Introduces Rules Restricting Application of Foreign Laws
(February 17, 2021) - Back to the Future: New Executive Order Restarts Myanmar Sanctions
(February 12, 2021) - Podcast: Communist Chinese Military Companies Executive Order: Implications and Key Questions
(February 11, 2021) - President Biden’s Buy American Executive Order Signals Possible Heightened False Claims Act Risk for Government Contractors
(February 11, 2021) - IRS Issues Final Regulations on Deductions of Certain Settlement Payments to Governments
(February 10, 2021)
News & Events
- Event: Outlook 2021 – Washington, D.C. Updates and Insights on Life Sciences and Health Care
(February 25, 2021) - In Law360, Margaux Hall Examines Drug Commercialization and Market Access Strategies in Light of Drug Pricing Regulatory Uncertainty Under the Biden Administration
(February 16, 2021) - In Managing Intellectual Property, IP Litigator Addresses Patent Eligibility Criteria Challenges
(February 16, 2021) - On BBC World Service Panel, Marta Belcher Discusses Cryptocurrency Regulation
(February 10, 2021) - In The New York Times, Craig Marcus Examines How Certain Winners are Cashing in on ‘Meme Stock’ Mania
(February 9, 2021)